Status:
COMPLETED
Prebiotic Effect on Metabolites in Crohn's Disease
Lead Sponsor:
KU Leuven
Conditions:
Crohn Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the influence of the prebiotic oligofructose enriched inulin on the metabolite pattern in Crohn's disease patients.
Eligibility Criteria
Inclusion
- crohn's disease
Exclusion
- severe crohn's disease (harvey bradshaw index \>12)
- pregnancy
- history of colectomy
- use of antibiotics 4-wks before start of the study
- use of sulfapyridine
- use of commercially available prebiotics and probiotics
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT01487759
Start Date
March 1 2008
End Date
July 1 2009
Last Update
December 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KULeuven
Leuven, Belgium, 3000